Cost-effectiveness of live oral attenuated human rotavirus vaccine in Tanzania

201531 citationsJournal Articlegold Open Access

Authors

George Mugambage Ruhago · University of Bergen

Bjarne Robberstad · University of Bergen

Ole Frithjof Norheim · University of Bergen

Abstract

The combination of rotavirus immunisation with diarrhoea treatment is likely to be cost effective when willingness to pay for health is higher than USD 112 per DALY. Universal coverage of the vaccine will accelerate progress towards achievement of the child health Millennium Development Goals.

Topics & Keywords

Viral gastroenteritis research and epidemiology Vaccine Coverage and Hesitancy Hepatitis Viruses Studies and Epidemiology

Publication Details

Published in: Cost Effectiveness and Resource Allocation

Volume 13, Issue 1, pp. 7-7

DOI: 10.1186/s12962-015-0033-0

Field-Weighted Citation Impact: 0.39

Command Palette

Cost-effectiveness of live oral attenuated human rotavirus vaccine in Tanzania

Authors

Abstract

Topics & Keywords

Publication Details